BehaVR is partnering with Sumitomo Dainippon Pharma to develop a VR solution to assist in the management of social anxiety disorder
Cerevel Therapeutics, specialising in neurological disorders, and Cyclica, an AI drug discovery company, are collaborating to accelerate the research and discovery of novel mediciines for neuro diseases
The WHO today announces the launch of the COVID-19 Technology Access Pool (C-TAP), a global open collaboration in the fight against COVID-19 to make vaccines, drugs and other health technologies against COVID-19 accessible to all.
Owlstone Medical enters collaboration agreement with Actelion to develop breath-based diagnostic test for pulmonary hypertension.
The Global Commission to End the Diagnostic Odyssey for Children has today published recommendations on how to solve the challenge of diagnosing rare diseases. The commission was set up by Takeda, Microsoft, and EURORDIS-Rare Diseases Europe to find solutions to core barriers preventing timely diagnosis for rare diseases.
A collaboration between Aether, the Californian bioprinter startup, and University College London (UCL) promises to develop a powerful new approach to 3D printing nanotechnology, while greatly reducing the cost compared with competitor offerings.
Medical researchers in Britain and Japan are to join forces in the fight to advance research into treatments for some of the most debilitating degenerative diseases.